Drug Type Antibody drug conjugate (ADC) |
Synonyms |
Target |
Mechanism CD73 inhibitors(5'-nucleotidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC40H59NO11 |
InChIKeyUFNVPOGXISZXJD-JBQZKEIOSA-N |
CAS Registry253128-41-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 1 | US | - | |
CD73 Expressing Solid Tumors | IND Approval | CN | 28 Jan 2023 |